Synlett 2008(18): 2851-2855  
DOI: 10.1055/s-0028-1083502
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Cyclic Sulfonamides via Pd-Catalyzed Intramolecular Coupling Reaction: An Expedient Approach to Polycyclic Sultams

K. C. Majumdar*, Shovan Mondal, Nirupam De
Department of Chemistry, University of Kalyani, Kalyani 741235, WB, India
Fax: +91(33)25828282; e-Mail: kcm_ku@yahoo.co.in;
Further Information

Publication History

Received 7 July 2008
Publication Date:
15 October 2008 (online)

Abstract

A divergent synthetic approach to polycyclic sultams utilizing intramolecular ligand-free intramolecular coupling reaction is described.

    References and Notes

  • 1a Drews J. Science  2000,  287:  1960 
  • 1b Scozzafava A. Owa T. Mastrolorenzo A. Supuran CT. Curr. Med. Chem.  2003,  10:  925 
  • 2a Gennari C. Salom B. Potenza D. Williams A. Angew. Chem., Int. Ed. Engl.  1994,  33:  2067 
  • 2b Moree WJ. van der Marel GA. Liskamp RMJ. J. Org. Chem.  1995,  60:  5157 
  • 2c Gennari C. Nestler HP. Salom B. Still WC. Angew. Chem., Int. Ed. Engl.  1995,  34:  1765 
  • 2d Roush WR. Gwaltney SL. Cheng J. Scheidt KA. McKerrow JH. Hansell E. J. Am. Chem. Soc.  1998,  120:  10994 
  • 3a Ghosh AK. Kincaid JF. Cho W. Walters DE. Krishnan K. Hussain KA. Koo Y. Cho H. Rudall C. Holland L. Buthod J. Bioorg. Med. Chem. Lett.  1998,  8:  687 
  • 3b Radkiewicz JL. McAllister MA. Goldstein E. Houk KN. J. Org. Chem.  1998,  63:  1419 
  • 4a Kim SW. Hong CY. Lee EJ. Koh JS. Bioorg. Med. Chem. Lett.  1998,  8:  735 
  • 4b Jones-Hertzog DK. Jorgensen WL. J. Med. Chem.  1997,  40:  1539 
  • 5 Brashear KM. Cook JJ. Bednar B. Bednar RA. Gould RJ. Halczenko W. Holahan MA. Lynch RJ. Hartman GD. Hutchinson JH. Bioorg. Med. Chem. Lett.  1997,  7:  2793 
  • 6 Bradbury RH. Bath C. Butlin RJ. Dennis M. Heys C. Hunt SJ. James R. Mortlock AA. Summer NF. Tang EK. Telford B. Whiting E. Wilson C. J. Med. Chem.  1997,  40:  996 
  • 7 Hanessian S. Sailes H. Therrien E. Tetrahedron  2003,  59:  7047 
  • 8a Silvestri R. Marfe G. Artico M. La Regina G. Lavecchia A. Novellino E. Morgante M. Di Stefano C. Catalano G. Filomeni G. Abruzzese E. Ciriolo MR. Russo MA. Amadori S. Cirilli R. La Torre F. Salimei PS. J. Med. Chem.  2006,  49:  5840 
  • 8b Lebegue N. Gallet S. Flouquet N. Carato P. Pfeiffer B. Renard P. Leonce S. Pierre A. Chavatte P. Berthelot P. J. Med. Chem.  2005,  48:  7363 
  • 9 Wroblewski T. Graul A. Castaner J. Drugs Future  1998,  23:  365 
  • 10 Rabasseda X. Hopkins SJ. Drugs Today  1994,  30:  557 
  • 11 Inagaki M. Tsuri T. Jyoyama H. Ono T. Yamada K. Kobayashi M. Hori Y. Arimura A. Yasui K. Ohno K. Kakudo S. Koizumi K. Suzuki R. Kato M. Kawai S. Matsumoto S. J. Med. Chem.  2000,  43:  2040 
  • 12 McKerrecher D, Pike KG, and Waring MJ. inventors; WO  2006125972. 
  • 13 Brzozowski Z. Saczewski F. Neamati N. Bioorg. Med. Chem. Lett.  2006,  16:  5298 
  • 14a Bravo RD. Canepa AS. Synth. Commun.  2002,  32:  3675 
  • 14b Orazi OO. Corral RA. Bravo R. J. Heterocycl. Chem.  1986,  23:  1701 
  • 14c Katritzky AR. Wu J. Rachwal S. Rachwal B. Macomber DW. Smith TP. Org. Prep. Proced. Int.  1992,  24:  463 
  • 15 Lee J. Zhong Y.-L. Reamer RA. Askin D. Org. Lett.  2003,  5:  4175 
  • 16 Enders D. Moll A. Bats JW. Eur. J. Org. Chem.  2006,  1271 
  • 17 Chiacchio U. Corsaro A. Rescifina A. Bkaithan M. Grassi G. Piperno A. Tetrahedron  2001,  57:  3425 
  • 18a Metz P. Seng D. Frohlich R. Synlett  1996,  741 
  • 18b Plietker B. Seng D. Frohlich R. Metz P. Tetrahedron  2000,  56:  873 
  • 18c G reig IR. Trozer MJ. Wright PT. Org. Lett.  2001,  3:  369 
  • 19 Zhou A. Hanson PR. Org Lett.  2008,  10:  2951 
  • 20 Liu X.-Y. Li C.-H. Che C.-M. Org. Lett.  2006,  8:  2707 
  • 21a Dauban P. Dodd RH. Org. Lett.  2000,  2:  2327 
  • 21b Dauban P. Saniere L. Aurelie T. Dodd RH. J. Am. Chem. Soc.  2001,  123:  7707 
  • 21c Sherman ES. Chemler SR. Tan TB. Gerlits O. Org. Lett.  2004,  6:  1573 
  • 22a Liang J.-L. Yuan S.-X. Chan PWH. Che C.-M. Org. Lett.  2002,  4:  4507 
  • 22b Padwa A. Flick AC. Leverett CA. Stengel T. J. Org. Chem.  2004,  69:  6377 
  • 22c Hopkins MJ. Hanson PR. Org. Lett.  2008,  10:  2223 
  • 23 Hanson PR. Probst DA. Robinson RE. Yau M. Tetrahedron Lett.  1999,  40:  4761 
  • 24a Merten S. Frohlich R. Kataeva O. Adv. Synth. Catal.  2005,  347:  754 
  • 24b Vasudevan A. Tseng P.-S. Djuric SW. Tetrahedron Lett.  2006,  47:  8591 
  • 25a Majumdar KC. Chakravorty S. De N. Tetrahedron Lett.  2008,  49:  3419 
  • 25b Majumdar KC. Chattopadhaya B. Ray K. Tetrahedron Lett.  2007,  48:  7633 
  • 25c Majumdar KC. Chattopadhaya B. Nath S. Tetrahedron Lett.  2008,  49:  1609 
  • 26a Majumdar KC. Mondal S. Tetrahedron Lett.  2007,  48:  6951 
  • 26b Majumdar KC. Mondal S. Tetrahedron Lett.  2008,  49:  2418 
  • 27 Reilly TP. Ju C. Curr. Opin. Allergy Clin. Immunol.  2002,  2:  307 
  • 29 Jeffery T. J. Chem. Soc., Chem. Commun.  1984,  1287 
  • 32 Beletskaya IP. Cheprakov AV. Chem. Rev.  2000,  100:  3009 
28

Compound 3a: white solid, mp 133-134 ˚C; yield 95%. IR (KBr): 1342, 1160 cm. ¹H NMR (400 MHz, CDCl3): δ = 2.45 (s, 3 H), 4.50 (s, 4 H,), 6.99 (t, 2 H, J = 7.8 Hz), 7.13 (t, 2 H, J = 8.4 Hz), 7.33 (t, 6 H, J = 8.4 Hz), 7.73 (d, 2 H, J = 8.2 Hz). ¹³C NMR (75 MHz, CDCl3): δ = 21.4, 52.2, 123.2, 127.1, 127.2, 128.8, 129.7, 130.0, 132.4, 134.7, 136.4, 143.5. HRMS: m/z calcd for C21H19Br2NO2S: 529.9335 [M + Na], 531.9381 [M + 2 + Na], 533.9339 [M + 4 + Na]; found: 529.9401 [M + Na], 531.9401 [M + 2 + Na], 533.9401 [M + 4 + Na].

30

General Procedure for the Synthesis of Compounds 7a-f by the Intramolecular Coupling Reaction A mixture of 3a (200 mg, 0.39 mmol), TBAB (153 mg, 0.47 mmol), and dry KOAc (106 mg, 1.08 mmol) was taken up in anhyd DMF (5 mL) under a nitrogen atmosphere. Palladium acetate (9 mg, 0.039 mmol) was added, and the reaction mixture was stirred at 120 ˚C for 10 h. The reaction mixture was cooled and H2O (25 mL) was added. The aqueous layer was extracted with EtOAc (3 × 30 mL), and the organic layer was washed with H2O (2 × 40 mL) followed by brine (30 mL). The organic layer was dried (Na2SO4), and the solvent was removed in vacuo. The crude product was purified by silica gel column chromatography using EtOAc-PE (1:9) to afford the product 7a. The other substrates 3b-f were similarly treated to give products 7b-f.
Compound 7a: white solid, mp 241-242 ˚C; yield 85%. IR (KBr): 1462, 1317, 1149 cm. ¹H NMR (400 MHz, CDCl3): δ = 2.52 (s, 3 H), 3.86 (d, 1 H, J = 15.1 Hz), 4.11-4.19 (q, 2 H, J = 11.8 Hz), 4.45 (d, 1 H, J = 15.1 Hz), 7.34-7.37 (m, 1 H), 7.39-7.44 (m, 2 H), 7.49-7.54 (m, 3 H), 7.57-7.62 (m, 3 H), 8.25 (d, 1 H, J = 8.2 Hz). ¹³C NMR (75 MHz, CDCl3): δ = 21.5, 48.6, 49.2, 127.3, 127.4, 127.6, 128.5, 128.8, 129.0, 129.2, 129.7, 130.9, 133.7, 134.6, 136.2, 137.5, 139.5, 141.2, 144.9. HRMS: m/z calcd for C21H17NO2S: 370.0878 [M + Na]; found: 370.0878 [M + Na].

31

The CCDC reference number for the CIF file of compound 7a: CCDC-693638.